Englisch, S. A., Meyer-Lindenberg, A., & Zink, M. (2018). Neurocognitive effects of agomelatine treatment in schizophrenia patients suffering from comorbid depression: Results from the AGOPSYCH study. Journal of clinical psychopharmacology, 38(4), . https://doi.org/10.1097/JCP.0000000000000909
Chicago-Zitierstil (17. Ausg.)Englisch, Susanne Angelika, Andreas Meyer-Lindenberg, und Mathias Zink. "Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering from Comorbid Depression: Results from the AGOPSYCH Study." Journal of Clinical Psychopharmacology 38, no. 4 (2018). https://doi.org/10.1097/JCP.0000000000000909.
MLA-Zitierstil (9. Ausg.)Englisch, Susanne Angelika, et al. "Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering from Comorbid Depression: Results from the AGOPSYCH Study." Journal of Clinical Psychopharmacology, vol. 38, no. 4, 2018, https://doi.org/10.1097/JCP.0000000000000909.